MEDIPEAU Participates in Dubai Derma 2025, Accelerates Entry into the Global Skin Solution Market > VLOG

MEDIPEAU, a specialized medical device company focused on skin health, participated in “Dubai Derma 2025,” the largest dermatology and aesthetics exhibition in the Middle East and North Africa (MENA) region, held in Dubai, UAE, in April 2025. The company showcased its flagship lineup of medical device-based skin solution products.

Dubai Derma is recognized as one of the world’s most authoritative exhibitions in the field of dermatology and aesthetics. This year, the event was held on its largest-ever scale, drawing over 25,000 buyers from 114 countries. With a significant number of professionals—from medical experts to distributors and hospital representatives—in attendance, attention to K-beauty and advanced Korean medical device technology was especially remarkable, bringing increased interest to the booths of Korean companies.

MEDIPEAU drew considerable attention at the event by presenting a diverse range of medical device-based skin protection and regeneration solutions.

Among its offerings at the exhibition, MEDIPEAU introduced the "BARRICURE" series for skin barrier recovery and wound protection, as well as the "OCUCARE" product line dedicated to periocular skin care. The display demonstrated the company’s technology and product competitiveness in the market for post-procedure skin protection and regeneration. Special emphasis was placed on hypoallergenic formulas designed for sensitive skin and the safety ensured by medical device certification, leading to active consultations with local distributors and healthcare professionals. These efforts established a strong foothold for MEDIPEAU’s entry into the MENA region.

A representative from MEDIPEAU stated, “Participating in Dubai Derma has provided us with a valuable opportunity to further enhance our technological capabilities and brand recognition in the global marketplace. Moving forward, we will continue to participate in international exhibitions and expand partnerships to become a global leader in medical device-based skin solutions.”